Nephrology News

The FDA has granted a prior approval supplement to Zydus Lifesciences Limited allowing the company to market its generic mycophenolate mofetil injection USP, 500 mg vial, following a transfer to a new manufacturing site.

Cathleen M. McCabe, MD, and Laura B. Enyedi, MD, talk with Jaya B. Kumar, MD, FASRS, and Jullia A. Rosdahl, MD, PhD, about addressing physician suicide and destigmatizing mental health. Plus, they share their favorite resilience hacks.

Intent-to-treat survival among pediatric patients who have received a heart, liver or kidney transplant steadily improved over the past 3 decades, according to a study of more than 47,000 transplants.

The European Union, and specifically Norway, has demonstrated successful strategies for making biosimilars available for patients — and realizing “tremendous savings” — that should be adopted in the United States, according to an analysis.

The omicron variant of SARS-CoV-2 now accounts for 95% of COVID-19 cases in the United States, CDC Director Rochelle P. Walensky, MD, MPH, said during a White House briefing on Wednesday.

The Mediterranean diet has been named the best overall diet for the fifth year in a row by the editors of U.S. News & World Report.

Although COVID-19 remained a popular topic among Healio Primary Care readers in 2021, other stories that discussed diabetes screening and physician suicide also generated significant attention.

As of Dec. 1, the FDA had approved 46 novel drugs this year, one fewer than it had approved by the same date in 2020.

Patients with lupus nephritis who receive voclosporin demonstrated “meaningful reductions” in proteinuria with no change in mean estimated glomerular filtration rate at 30 months, according to data presented at ACR Convergence 2021.

Race and residence are both independently associated with lupus nephritis mortality, with Black patients and those living in large central metropolitan areas demonstrating the highest rates, according to data presented at ACR Convergence 2021.